Valeric Acid

Valeric Acid

SCHEMBL30236295

CCCCC(=O)O.CCCCC(=O)O.CCCCC(=O)O.O=CO

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.67
GPR84 Q9NQS5 7/20 0.64
PPARG P37231 7/20 0.64
PPARD Q03181 7/20 0.64
PPARA Q07869 7/20 0.64
HDAC11 Q96DB2 5/20 0.64
TSHR P16473 4/20 0.64
PTPN1 P18031 3/20 0.64
FABP4 P15090 3/20 0.64
ALDH1A1 P00352 2/20 0.64
TLR2 O60603 2/20 0.64
TDP1 Q9NUW8 2/20 0.64
KMT2A Q03164 2/20 0.64
ALOX15 P16050 2/20 0.64
HSD17B10 Q99714 2/20 0.64
SLC22A6 Q4U2R8 1/20 0.64
SLC22A8 Q8TCC7 1/20 0.64
MEN1 O00255 1/20 0.64
ESR1 P03372 1/20 0.64
PDE4A P27815 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valeric Acid SCHEMBL28239218 1.00 AKR1B1 (0.67) AKR1B1GPR84PPARGPPARDPPARA
Valeric Acid SCHEMBL15261405 1.00 AKR1B1 (0.67) AKR1B1GPR84PPARGPPARDPPARA
Valeric Acid SCHEMBL29009717 0.97 AKR1B1 (0.64) AKR1B1GPR84PPARGPPARDPPARA
Valeric Acid SCHEMBL29199834 0.95 AKR1B1 (0.61) AKR1B1GPR84PPARGPPARDPPARA
Hexanoate SCHEMBL12817011 0.92 AKR1B1 (0.80) AKR1B1GPR84PPARGPPARDPPARA
Hexanoate SCHEMBL12817527 0.92 AKR1B1 (0.80) AKR1B1GPR84PPARGPPARDPPARA
Hexanoate SCHEMBL27603848 0.92 AKR1B1 (0.80) AKR1B1GPR84PPARGPPARDPPARA
Hexanoate SCHEMBL15260773 0.92 AKR1B1 (0.80) AKR1B1GPR84PPARGPPARDPPARA
Stearic Acid SCHEMBL2199497 0.90 GPR84 (0.81) AKR1B1GPR84PPARGPPARDPPARA
Octanoic Acid SCHEMBL9421271 0.90 GPR84 (0.81) AKR1B1GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047296-A1 Nrf2 REGULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230047296-A1 Nrf2 REGULATORS NFE2L2, KEAP1, NQO1 AKR1B1 360/4885GPR84 1158/4885PPARG 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.